Top compounds associated with response to ASXL3


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan FIMM pan-cancer AAC -0.16 0.3
mRNA AP-24534 FIMM pan-cancer AAC -0.16 0.3
mRNA AS601245 GDSC1000 pan-cancer AAC -0.16 9e-06
mRNA Dasatinib FIMM pan-cancer AAC -0.16 0.3
mRNA bid1870 gCSI pan-cancer AAC -0.16 0.004
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.15 0.4
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.15 3e-06
mRNA Vorinostat FIMM pan-cancer AAC -0.15 0.3
mRNA Erlotinib gCSI pan-cancer AAC -0.15 0.009
mRNA Topotecan FIMM pan-cancer AAC -0.15 0.2
Download CSV